ENODIA THERAPEUTICS

Serial Number 79402800
686

Registration Progress

Application Filed
Jul 10, 2024
Under Examination
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 07, 2025 13 days

Trademark Image

ENODIA THERAPEUTICS

Basic Information

Serial Number
79402800
Filing Date
July 10, 2024
Published for Opposition
July 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 8, 2025
Application
Pending
Classes
005 042

Rights Holder

Argobio

34
Address
8 rue François Villon
F-75015 Paris
FR

Ownership History

Argobio

Original Applicant
34
FR

Argobio

Owner at Publication
34
FR

Legal Representation

Attorney
Mark L. Weber

USPTO Deadlines

Next Deadline
13 days remaining
Notice of Publication
Due Date
August 07, 2025
Extension Available
Until September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 7, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 22, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 4, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 3, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 31, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 26, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 22, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of autoimmune diseases, neurodegenerative diseases, cancer, inflammatory diseases, and viral infections
Class 042
Pharmaceutical research and development

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"